Herpes Serology: HSV-1 and HSV-2 Type-Specific Diagnosis from the Public Health Perspective

SPONSORED BY: DiaSorin, DiaSorin
9 49 9372

  • Director, Public Health Laboratory, State of Tennessee Department of Health
      Dr. Richard Steece is certified as the Public Health Laboratory Director at the State of Tennessee Department of Health. He came into this role with over 30 years of experience and is one of the nation's leading public health laboratory experts. Among his multiple admirable roles driving public health initiatives, Dr. Steece has recently served as the National Chlamydia Laboratory Coordinator for the Centers for Disease Control and Prevention (CDC) and as Science Advisor to the Association of Public Health Laboratories (APHL). Most recently, Dr. Steece is the incoming chair of the 2015 STD subcommittee for APHL, and he is continuing this appointment into 2016. Prior to his public health career working with every city, county and state public health laboratory in the US, Dr. Steece earned his PhD in Biology/Microbiology.


    Serology testing continues to be an indispensable tool for the management of several disease states, especially for the qualitative determination IgG antibodies to Herpes simplex virus Type 1 (HSV-1) or Herpes simplex virus Type 2 (HSV-2) in human serum.
    Come to this educational seminar to learn about key objectives in HSV-1 or HSV-2 type-specific diagnosis:

    • Examine how serology assays may be indicated in certain clinical scenarios: in sexually active adults or expectant mothers to aid in the presumptive diagnosis of HSV-1 or HSV-2 type-specific infection.
    • Discuss the US clinical guidelines regarding why HSV-1 and HSV-2 type-specific screening is not indicated in the general US population as it is for other STDs.
    • Describe diagnostic methods for diagnosing HSV-1 or HSV-2 type-specific infection: the differences between virologic and serologic assays and their usefulness in herpes diagnosis.

    Show Resources
    Loading Comments...